SANTA CLARA, Calif., June 13, 2019 /PRNewswire/ — More United States hospitals are responding to the influx of connected medical devices by reorganizing legacy patient care networks and traditional IT and Biomed departments, placing clinical engineers and IT specialists under the same department. These hospitals recognize that reliable medical device networks require Biomedical and IT departments that work effectively together to leverage digital tools that proactively scan the network for anomalies.
Frost & Sullivan’s virtual think tank, Best Practices for Managing Patient Monitoring Networks Across the IT and Biomedical Departments, aims to understand what best practices successful hospitals were following to keep these critical pieces of infrastructure functional and focused on supporting patient care.
To download the Virtual Think Tank Executive Summary, please visit: http://frost.ly/3ge.
Software solutions that can help to proactively monitor these growing and increasingly complex networks should be part of every facility’s strategy for reducing the impact of outages and data loss. The results of the survey include:
“This dependency on information makes the network one of the most important pieces of health IT infrastructure. Consistent network functionality allows providers to interact with clinical information faster, thereby expediting patient care,” noted Charlie Whelan, Transformational Health Vice President of Consulting. “As organizations continue upgrading their clinical networks and introducing a greater number of medical devices to their digital environments, managing clinical networks will become increasingly complex.”
The following industry thought leaders participated in this virtual think tank: Laura Groselle, Manager of Clinical Engineering at Cleveland Clinic; Richard Straub, Director of Clinical Engineering Biomed Services at UPMC; Christopher George, Biomedical Engineering Supervisor at Lancaster General Hospital; Ricardo Ortiz, Biomed Manager at United Regional Medical Center; Tony Alongi, System Director of Clinical Engineering at Rochester General Hospital; and Lou Kowatch, Senior Director of Healthcare Digital Service at GE Healthcare.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today’s market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Contact us: Start the discussion.
About GE Healthcare:
GE Healthcare is the $19.8 billion healthcare business of GE (NYSE: GE). As a leading provider of medical imaging, monitoring, biomanufacturing, and cell and gene therapy technologies, GE Healthcare enables precision health in diagnostics, therapeutics and monitoring through intelligent devices, data analytics, applications and services. With over 100 years of experience in the healthcare industry and more than 50,000 employees globally, the company helps improve outcomes more efficiently for patients, healthcare providers, researchers and life sciences companies around the world. Follow us on Facebook, LinkedIn, Twitter and The Pulse for latest news, or visit our website https://corporate.gehealthcare.com/ for more information.
Contact:
Francesca Valente
Corporate Communications
P: +1 (210) 348.1012
E: francesca.valente@frost.com
http://ww2.frost.com
View original content:http://www.prnewswire.com/news-releases/consolidating-the-it-and-biomedical-departments-will-be-vital-to-avoid-clinical-network-failures-300867174.html
SOURCE Frost & Sullivan
NEWARK, DE / ACCESSWIRE / November 22, 2024 / Laurel Bridge Software, a leader in…
DENVER, CO / ACCESSWIRE / November 22, 2024 / Aytu BioPharma, Inc. (the "Company" or…
Hemogenyx Pharmaceuticals plc("Hemogenyx Pharmaceuticals" or the "Company")Notice of Extraordinary General MeetingProposed Capital Reorganisation and New…
Diarrhea is one of the most common reasons for veterinary visits for dogs and the…
Developing innovative bispecific antibodies for monotherapy and combination with the potential to expand the frontiers…
FORT LAUDERDALE, FL / ACCESSWIRE / November 22, 2024 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the…